SGLT2 inhibition by intraperitoneal dapagliflozin mitigates peritoneal fibrosis and ultrafiltration failure in a mouse model of chronic peritoneal exposure to high-glucose dialysate
Michael S. Balzer(Penn Center for AIDS Research), Nelli Shushakova(Medizinische Hochschule Hannover)
Cited by 13
Related Papers
Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regeneration
|Nature Communications|2022|186
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
|Cell Metabolism|2020|171